Market Alert: Rising Rhetoric from Radical Ideological Conservatives Sparks Concerns in U.S. Equity Markets

The Calmer Co Accelerates Sales Growth with Strong July August Momentum.

Sep 04, 2025

The Calmer Co. International Limited (ASX: CCO) has reported strong sales momentum for July and August 2025, reflecting the success of its operational turnaround in H2 FY25. After cutting total expenses by 27% and reducing operating losses by 33% through tighter cost controls and platform efficiencies, the company has shifted to a leaner, more scalable model. July sales reached AU$715 thousand, followed by AU$838 thousand in August, representing a 17% uplift and positioning the business on an annualised sales run-rate above AU$10 million.

Growth was further supported by Amazon USA, where sales climbed from AU$192 thousand in July to AU$214 thousand in August, driven by the launch of new Taki Mai flavoured kava shots. Market share on the platform rose to 7% from 3% a year earlier, while subscription sales and organic visibility surged. With retail growth in Coles and Woolworths and expansion in the US wellness market, CCO is well placed for FY26.

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com